These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32800318)

  • 1. [Atrial fibrillation and QT prolongation due to proton pump inhibitor-induced hypomagnesemia].
    Noirclerc N; Delfanne C; Dompnier A
    Ann Cardiol Angeiol (Paris); 2020 Oct; 69(4):201-203. PubMed ID: 32800318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.
    Uehara A; Kita Y; Sumi H; Shibagaki Y
    Intern Med; 2019 Aug; 58(15):2201-2205. PubMed ID: 30996187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
    Chrysant SG; Chrysant GS
    Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
    [No Abstract]   [Full Text] [Related]  

  • 4. [A patient with inflammatory arthralgia, paraesthesia and atrial fibrillation].
    Vossen D; Nehls V
    Z Rheumatol; 2020 Feb; 79(1):78-82. PubMed ID: 31776649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
    Swaminathan K
    Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia.
    Civardi C; Collini A; Geda C
    Parkinsonism Relat Disord; 2020 Mar; 72():80-81. PubMed ID: 32146379
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe hypomagnesaemia due to proton pump inhibitor use].
    van den Berg S; Scheer MLJ; Holman ND
    Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
    Hughes J; Y Y Chiu D; Kalra PA; Green D
    PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long QT interval resembling long QT syndrome in a newborn with electrolyte dysbalance.
    Ayangade-Johnson G; Villafane J
    J Ky Med Assoc; 2001 Jul; 99(7):285-7. PubMed ID: 11468869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurological symptoms of hypomagnesemia].
    Cakici M; van Steenkiste J; Assink JH; Moudrous W
    Ned Tijdschr Geneeskd; 2021 Nov; 165():. PubMed ID: 35129888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypomagnesemia associated with a proton pump inhibitor.
    Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H
    Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy.
    Cabras P; Anedda M; Caddeo L; Francesco M; Antonella M
    Am J Ther; 2020; 27(6):e676-e680. PubMed ID: 31425160
    [No Abstract]   [Full Text] [Related]  

  • 18. A Very Rare Side Effect of a Very Commonly Used Drug: Pantoprazole-induced Seizure.
    Anandan S; Rajendran SS; Somarajan SA; Udayan A
    J Assoc Physicians India; 2024 Aug; 72(8):89. PubMed ID: 39163076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.